Tissue-specific Activation

Tissue-Specific Activation is a bioprecursor prodrug strategy that belongs to the class of site-selective drug delivery mechanisms, distinguished by its reliance on enzymatic or physiological conditions unique to particular tissues to selectively convert an inactive prodrug into its active pharmacological form.

102

Publications

9.8K

Citations

559

Authors

202

Institutions

Publications per year

2017–2026

19

Variants

Tissue-selective Activation

Authors

559

  1. ÀP
    Àngel Pellicer

    New York University, United States

    2 publications · 267 citations

    2

    h-index

  2. AC
    Allan C. Spradling

    Carnegie Institution for Science, United States

    2 publications · 113 citations

    2

    h-index

  3. TL
    Thomas Lattmann

    University Hospital of Zurich, Switzerland

    2 publications · 176 citations

    2

    h-index

  4. TL
    Terry L. Orr‐Weaver

    Whitehead Institute for Biomedical Research, United States

    2 publications · 113 citations

    2

    h-index

  5. FZ
    F Zajdela

    Institut Curie, France

    2 publications · 31 citations

    2

    h-index

1–5 of 559

Venues

  1. Molecular and Cellular Biology

    MCB · 8 publications · 1K citations

    8

    h-index

  2. Journal of Biological Chemistry

    JBC · 7 publications · 749 citations

    7

    h-index

  3. PubMed

    Repository · 6 publications · 150 citations

    6

    h-index

  4. Genes & Development

    5 publications · 1.1K citations

    5

    h-index

  5. Physics in Medicine and Biology

    4 publications · 176 citations

    4

    h-index

1–5